Literature DB >> 28873590

In silico analysis and molecular docking study of angiotensin I-converting enzyme inhibitory peptides from smooth-hound viscera protein hydrolysates fractionated by ultrafiltration.

Ola Abdelhedi1, Rim Nasri2, Letica Mora3, Mourad Jridi2, Fidel Toldrá3, Moncef Nasri2.   

Abstract

Smooth-hound viscera hydrolysates (SHVHs) were prepared by treatment with Neutrase (SHVH-N) and Purafect (SHVH-P). Hydrolysates were then separated according to their molecular weight, using the ultra-filtration membrane system, into 5 fractions (≥50, 50-5, 5-3, 3-1 and ≤1kDa). Fractions showed different amino acid compositions and angiotensin I-converting enzyme (ACE) inhibitory potentials. The SHVH-P-FV (≤1kDa) and SHVH-N-FIV (3-1kDa) fractions showed the best ACE-inhibitory activities with IC50 values of 53.31 and 75.05µg/ml, respectively. According to their high ACE-inhibitory potential, FIV and FV were fractionated by RP-HPLC and then analyzed by LC-MS/MS to identify peptide sequences. A systematic peptidomic study resulted in the identification of numerous novel sequences. Furthermore, in silico data, based on the molecular docking simulation, showed that GPAGPRGPAG, AVVPPSDKM, TTMYPGIA, and VKPLPQSG could bind ACE active site with low interaction scores. Indeed, they share hydrogen bonds and Van der Waals and electrostatic interactions with ACE catalytic pockets.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ACE-inhibitory peptides; In silico screening; Molecular docking; Smooth-hound viscera; Ultra-filtration

Mesh:

Substances:

Year:  2017        PMID: 28873590     DOI: 10.1016/j.foodchem.2017.06.112

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  17 in total

1.  Purification and Identification of a Novel Angiotensin Converting Enzyme Inhibitory Peptide from the Enzymatic Hydrolysate of Lepidotrigla microptera.

Authors:  Xuejia Hu; Zhiyuan Dai; Renyao Jin
Journal:  Foods       Date:  2022-06-26

2.  Molecular insights into the interaction of hemorphin and its targets.

Authors:  Amanat Ali; Bincy Baby; Soja Saghar Soman; Ranjit Vijayan
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

3.  Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish (Actinopyga lecanora) hydrolysates.

Authors:  Shehu Muhammad Auwal; Najib Zainal Abidin; Mohammad Zarei; Chin Ping Tan; Nazamid Saari
Journal:  PLoS One       Date:  2019-05-30       Impact factor: 3.240

4.  Identification, Characterization and Antihypertensive Effect In Vivo of a Novel ACE-Inhibitory Heptapeptide from Defatted Areca Nut Kernel Globulin Hydrolysates.

Authors:  Xing Liu; Guanwen Li; Huimin Wang; Nan Qin; Lili Guo; Xiaomin Wang; Sang Shen
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

5.  Computational Study on Temperature Driven Structure-Function Relationship of Polysaccharide Producing Bacterial Glycosyl Transferase Enzyme.

Authors:  Patricio González-Faune; Ignacio Sánchez-Arévalo; Shrabana Sarkar; Krishnendu Majhi; Rajib Bandopadhyay; Gustavo Cabrera-Barjas; Aleydis Gómez; Aparna Banerjee
Journal:  Polymers (Basel)       Date:  2021-05-28       Impact factor: 4.329

6.  Identification and Molecular Docking Study of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Enzymatic Hydrolysates of Cyclina sinensis.

Authors:  Fangmiao Yu; Zhuangwei Zhang; Liwang Luo; Junxiang Zhu; Fangfang Huang; Zuisu Yang; Yunping Tang; Guofang Ding
Journal:  Mar Drugs       Date:  2018-10-27       Impact factor: 5.118

7.  FeptideDB: A web application for new bioactive peptides from food protein.

Authors:  Thitima Panyayai; Chumpol Ngamphiw; Sissades Tongsima; Wuttichai Mhuantong; Wachira Limsripraphan; Kiattawee Choowongkomon; Orathai Sawatdichaikul
Journal:  Heliyon       Date:  2019-07-20

Review 8.  Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors.

Authors:  Julio Caballero
Journal:  Molecules       Date:  2020-01-11       Impact factor: 4.411

9.  Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study.

Authors:  Amanat Ali; Seham Abdullah Rashed Alzeyoudi; Shamma Abdulla Almutawa; Alya Nasir Alnajjar; Yusra Al Dhaheri; Ranjit Vijayan
Journal:  Biomolecules       Date:  2020-03-23

10.  Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase.

Authors:  Jingxian Liu; Jinghong Yang; Yuhe Hou; Zhenwei Zhu; Jie He; Hao Zhao; Xidong Ye; Dengke Li; Zhaohui Wu; Zhongxi Huang; Bingtao Hao; Kaitai Yao
Journal:  Cancer Cell Int       Date:  2019-12-21       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.